首页> 美国卫生研究院文献>other >The Number and Ratio of Positive Lymph Nodes Affect Pancreatic Cancer Patient Survival after Neoadjuvant Therapy and Pancreaticoduodenectomy

【2h】

The Number and Ratio of Positive Lymph Nodes Affect Pancreatic Cancer Patient Survival after Neoadjuvant Therapy and Pancreaticoduodenectomy

机译：新辅助治疗和胰十二指肠切除术后阳性淋巴结数目和比率影响胰腺癌患者的生存

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

AimsThis study is to examine the significance of the number and ratio of positive nodes in post neoadjuvant therapy pancreaticoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC).

机译：目的本研究旨在探讨新辅助治疗后胰十二指肠切除术（PD）对胰腺导管腺癌（PDAC）阳性结节数目和比率的重要性。

著录项

期刊名称 other
作者
Laurice K. Fischer; Matthew H. Katz; Sun M. Lee; Li Liu; Hua Wang; Gauri R. Varadhachary; Robert A. Wolff; Jeffrey E. Lee; Anirban Maitra; Christina L. Roland; Jason B. Fleming; Jeannelyn Estrella; Asif Rashid; Huamin Wang;
展开▼
作者单位

展开▼
年(卷),期 -1(68),2
年度 -1
页码 210–220
总页数 17
原文格式 PDF
正文语种
中图分类
关键词
Pancreatic cancer Number of positive nodes Lymph node ratio Survival Prognosis;

机译：胰腺癌;阳性淋巴结数目;淋巴结比率;生存率;预后;

相似文献

外文文献
中文文献
专利

1. The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy [J] . Fischer Laurice K., Katz Matthew H., Lee Sun M., Histopathology: Official Journal of the British Division of the International Academy of Pathology . 2016,第2期

机译：新辅助治疗和胰十二指肠切除术后阳性淋巴结的数目和比例影响胰腺癌患者的生存
2. Development and validation of a nomogram incorporating axillary lymph node ratio to predict survival in node-positive breast cancer patients after neoadjuvant chemotherapy [J] . Jianguo Lai, Zihao Pan, Peixian Chen, Japanese journal of clinical oncology. . 2019,第1期

机译：掺入腋窝淋巴结率的载体淋巴结比的开发和验证预测新辅助化疗后节点阳性乳腺癌患者的存活
3. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration [J] . Yue Yu, Ning Cui, Heng-Yu Li, BMC Cancer . 2016,第1期

机译：乳腺癌新辅助化疗后前哨淋巴结活检：对临床腋窝淋巴结阳性和阴性患者的回顾性比较评估，包括经细针穿刺确诊的腋窝淋巴结转移患者
4. Breast MRI radiomics for the pre-treatment prediction of response to neoadjuvant chemotherapy in node-positive breast cancer patients [C] . Karen Drukker, Iman El-Bawab, Alexandra Edwards, SPIE Conference on Computer-Aided Diagnosis . 2019

机译：乳腺MRI辐射射清，用于节点阳性乳腺癌患者对新辅助化疗的反应预处理预测
5. Evaluation of pathologic parameters and published nomograms in predicting non-sentinel lymph node metastases in female breast cancer patients with positive sentinel lymph nodes. [D] . Murch, Lisa Elaine. 2007

机译：在前哨淋巴结阳性的女性乳腺癌患者中预测非前哨淋巴结转移的病理参数和公布的列线图评估。
6. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients including those with axillary lymph node metastases confirmed by fine needle aspiration [O] . Yue Yu, Ning Cui, Heng-Yu Li, 2016

机译：乳腺癌新辅助化疗后前哨淋巴结活检：对临床腋窝淋巴结阳性和阴性患者的回顾性比较评估包括经细针穿刺确诊的腋窝淋巴结转移患者
7. Table 5.5.a.1 Tumor size and treatment (rate of resectability) Figure 5.5.a.2 Cumulative survival of the patients after pancreatectomy for TS1 cancer according to residual tumors Figure 5.5.a.3 Cumulative survival of the patients with TS1 cancer according to extent of lymph node dissection Figure 5.5.a.4 Combined resection of portal vein and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.5 Combined resection of peripancreatic plexus and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.6 Combined resection of peripancreatic plexus when there is no plexus infiltration and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.7 Combined resection of artery and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.8 Combined resection of portal vein and cumulative survival of the patients after pancreatectomy for TS2 (2.1-4.0 cm) cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.9 Combined resection of peripancreatic plexus and cumulative survival of the patients after pancreatectomy for TS2 (2.1-4.0 cm) cancer of UICC Stage IIa or IIb in the pancreatic head [O] . 2007

机译：表5.5.a.1肿瘤大小和治疗（重新切性率）图5.5.a.2根据残留肿瘤对TS1癌胰腺切除后患者的累积存活图5.5.A.3累积存活根据淋巴结解剖的程度，TS1癌症的患者图5.5.A.4在胰头胰腺IIA或IIB癌症术后胰岛切除术后的门静脉和累积患者的累积存活图5.5。 A.5在胰头术后IIA或IIB胰腺切除术后，患者胰腺癌丛和患者累积存活的组合图5.5.A.6当没有丛浸润时，围裙丛生的围嘴巴丛的切除胰腺切除术后胰腺切除术后胰腺炎癌症的累积存活图5.5.A.7在TS1癌症胰腺切除后患者的动脉和累积存活的组合UICC阶段IIA或IIB在胰头图5.5.A.8在胰头胰腺阶段IIA或IIB癌症的胰腺切除后，患者的门静脉和累积患者的累积存活率图5.5.A.9在胰头胰腺阶段IIA或IIB的胰腺切除术后胰腺切除术后患者患者患者患者的累积生存的组合和胰腺头

The Number and Ratio of Positive Lymph Nodes Affect Pancreatic Cancer Patient Survival after Neoadjuvant Therapy and Pancreaticoduodenectomy

摘要

著录项

相似文献

相关主题

期刊订阅